Stock & Company Details
Adc Therapeutics SA $ADCT
Price:
N/A
N/A
128M
$203M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.42
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ADCT technical indicators
Latest Adc Therapeutics SA (ADCT) indicator readings as of 2026-10-09.
ADCT's 14-day RSI is 74.9, in overbought territory. At $1.73 it is trading 34.3% below its 200-day moving average of $2.63, and above its 50-day average of $1.17. Price sits above the upper Bollinger Band ($0.89 to $1.58). ADX reads 21.6, sitting between trending and range-bound.
Overview
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
Finance Bot
Ask your questions
Start by typing a question below.
